Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company’s proprietary platform enables t...
Aura Biosciences CEO to speak at Morgan Stanley Global Healthcare Conference
Aura Biosciences grants new executives stock options priced at $7.43, plus RSUs
Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | AURA Stock News
Aura Biosciences (NASDAQ:AURA) Shares Up 6.5% - Here's What Happened